RAD001 in Advanced Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2013

Conditions
Soft Tissue SarcomasBone Sarcomas
Interventions
DRUG

RAD001

Trial Locations (8)

463-707

Seoul National University Bundang Hospital, Seongnam-si

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Unknown

Yeongnam University College of Medicine, Daegu

301-721

Chungnam National University Hospital, Daejeon

110-744

Seoul National University Hospital, Seoul

120-752

Yonsei Cancer Center, Seoul

126-1

Korea University, Seoul

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01830153 - RAD001 in Advanced Sarcoma | Biotech Hunter | Biotech Hunter